SecurityGSK / GlaxoSmithKline plc
InstitutionIndependence Bank Of Kentucky
Shares28,027
Value $ 1,130,000
Related 377372AG2 / Glaxosmithkline Cap Inc. 0.70% 03/18/16
377372AH0 / Glaxosmithkline Cap Inc. 2.80% 03/18/23
377372AJ6 / Glaxosmithkline Cap Inc. 4.20% 03/18/43
377372AA5 / Glaxosmithkline Cap Inc Guaranteed Notes 4.375% 04/15/14
377372AB3 / Glaxosmithkline Cap Inc Guaranteed Notes 5.375% 04/15/34
377373AC9 / Glaxosmithkline Capital 1.50% 05/08/17
377373AD7 / Glaxosmithkline Capital 2.85% 05/08/22
377372AC1 / Glaxosmithkline Capital 4.85% Guaranteed Notes 5/15/13
377372AD9 / Glaxosmithkline Capital 5.65% Guaranteed Notes 5/15/18
377372AE7 / Glaxosmithkline Capital 6.375% Guaranteed Notes 5/15/38
377373AB1 / Glaxosmithkline Capital .75% 05/08/15

Independence Bank Of Kentucky reports 2.06% increase in ownership of GSK / GlaxoSmithKline plc

August 07, 2018 - Independence Bank Of Kentucky has filed a 13F-HR form disclosing ownership of 28,027 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $1,130,000 USD as of June 30, 2018. Independence Bank Of Kentucky had filed a previous 13F-HR on April 18, 2018 disclosing 27,462 shares of GlaxoSmithKline plc at a value of $1,073,000 USD. This represents a change in shares of 2.06 percent and a change in value of 5.31 percent during the quarter.

Other investors with positions similar to Independence Bank Of Kentucky include Frontier Wealth Management LLC, R&F Capital Advisors LP, PARK CIRCLE Co, Krasney Financial LLC, Eagle Asset Management Inc, and Mackenzie Financial Corp.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR Glaxosmithkline PLC Sponsored ADR SPONSORED ADR 37733W105 39.70 28,027 2.06 1,130 5.31 22 35 3.22
2018-03-31 13F-HR Glaxosmithkline PLC Sponsored ADR SPONSORED ADR 37733W105 37.27 27,462 10.28 1,073 21.52 95 95 10.71
2017-12-31 13F-HR Glaxosmithkline PLC Sponsored ADR SPONSORED ADR 37733W105 24,902 883


CUSIP: 37733W105